Deutsche Bank’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-165,447
| Closed | -$2.94M | – | 5629 |
|
|
2018
Q3 | $2.94M | Buy |
165,447
+18,721
| +13% | +$321K | ﹤0.01% | 2607 |
|
|
2018
Q2 | $2.02M | Sell |
146,726
-87,086
| -37% | -$1.03M | ﹤0.01% | 2941 |
|
|
2018
Q1 | $2.13M | Buy |
233,812
+233,197
| +37,918% | +$1.29M | ﹤0.01% | 2820 |
|
|
2017
Q4 | $2K | Buy |
615
+519
| +541% | +$2.47K | ﹤0.01% | 4928 |
|
|
2017
Q3 | $0 | Sell |
96
-161,205
| -100% | -$225K | ﹤0.01% | 5229 |
|
|
2017
Q2 | $241K | Buy |
161,301
+62,301
| +63% | +$134K | ﹤0.01% | 3826 |
|
|
2017
Q1 | $253K | Buy |
99,000
+54,353
| +122% | +$126K | ﹤0.01% | 3464 |
|
|
2016
Q4 | $113K | Sell |
44,647
-77,113
| -63% | -$221K | ﹤0.01% | 4016 |
|
|
2016
Q3 | $375K | Buy |
121,760
+109,328
| +879% | +$341K | ﹤0.01% | 3339 |
|
|
2016
Q2 | $38K | Sell |
12,432
-9,591
| -44% | -$35.1K | ﹤0.01% | 4537 |
|
|
2016
Q1 | $66K | Buy |
22,023
+9,151
| +71% | +$29.9K | ﹤0.01% | 4222 |
|
|
2015
Q4 | $51K | Sell |
12,872
-13,746
| -52% | -$63.3K | ﹤0.01% | 4394 |
|
|
2015
Q3 | $121K | Sell |
26,618
-212,030
| -89% | -$1.11M | ﹤0.01% | 4012 |
|
|
2015
Q2 | $1.24M | Buy |
238,648
+48,327
| +25% | +$290K | ﹤0.01% | 2832 |
|
|
2015
Q1 | $1.19M | Sell |
190,321
-134,163
| -41% | -$774K | ﹤0.01% | 2782 |
|
|
2014
Q4 | $2.04M | Buy |
324,484
+288,657
| +806% | +$1.76M | ﹤0.01% | 2656 |
|
|
2014
Q3 | $216K | Sell |
35,827
-78,622
| -69% | -$537K | ﹤0.01% | 4020 |
|
|
2014
Q2 | $753K | Sell |
114,449
-16,131
| -12% | -$182K | ﹤0.01% | 3177 |
|
|
2014
Q1 | $3.11M | Buy |
130,580
+5,742
| +5% | +$83.3K | ﹤0.01% | 2125 |
|
|
2013
Q4 | $1.33M | Sell |
124,838
-103,583
| -45% | -$1.14M | ﹤0.01% | 2498 |
|
|
2013
Q3 | $3.04M | Sell |
228,421
-1,192
| -0.5% | -$18.8K | ﹤0.01% | 2184 |
|
|
2013
Q2 | $3.01M | Buy |
+229,613
| New | +$3.1M | ﹤0.01% | 1948 |
|
Other funds holding ECYT
Deutsche Bank's ECYT Position: Q4 2018 in Review
Deutsche Bank sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 165,447 shares — an estimated $2.94M sold.
Deutsche Bank first reported a position in ECYT in Q2 2013 and held it in 22 quarters. The position peaked at $3.11M in Q1 2014. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.
- Deutsche Bank reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
- Deutsche Bank sold 165,447 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $2.94M.
- Deutsche Bank first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 22 quarters.
- Deutsche Bank's Endocyte, Inc. Common Stock position peaked at $3.11M in Q1 2014.
- 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.
Based on Deutsche Bank's 13F filing for Q4 2018, filed 14 Feb 2019.